Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel Free SNY Stock Alerts

Sanofi (SNY) News Today

Sanofi logo
$44.24 -0.09 (-0.20%)
As of 09/4/2026 04:00 PM Eastern
Compare

Sanofi Latest News

Sanofi (NASDAQ:SNY) Receives Average Recommendation of "Hold" from Brokerages
September 2 at 1:59 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30997877
Sanofi (NASDAQ:SNY) Upgraded at Wall Street Zen
August 29, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30989305
Sanofi (NASDAQ:SNY) Rating Increased to Buy at Wall Street Zen
August 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-sanofi-nasdaq-sny-rating-increased-to-buy-at-wall-street-zen-2026-08-29/
Sanofi (NASDAQ:SNY) Receives Average Rating of "Hold" from Analysts
August 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-sanofi-nasdaq-sny-receives-average-rating-of-hold-from-analysts-2026-08-28/
US FDA approves updated COVID vaccines for 2026-27 season
August 27, 2026  |  reuters.comhttps://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-updated-covid-vaccines-2026-27-season-2026-08-27/
The Manufacturers Life Insurance Company Lowers Position in Sanofi $SNY
August 12, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-the-manufacturers-life-insurance-company-lowers-position-in-sanofi-sny-2026-08-12/
Dimensional Fund Advisors LP Trims Stock Holdings in Sanofi $SNY
August 12, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-dimensional-fund-advisors-lp-trims-stock-holdings-in-sanofi-sny-2026-08-12/
Why the Amlitelimab Setback Isn’t Enough to Sink Sanofi’s Multi-Billion Dollar Engine
August 10, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/why-amlitelimab-setback-isn-t-232940996.html
Sanofi (NASDAQ:SNY) Cut to "Hold" at Wall Street Zen
August 9, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sanofi-nasdaqsny-cut-to-hold-at-wall-street-zen-2026-08-09/
Sanofi 2026 Q2 - Results - Earnings Call Presentation
August 7, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4933453-sanofi-2026-q2-results-earnings-call-presentation
Sanofi Says EU Expands MenQuadfi Approval
August 5, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/sanofi-says-eu-expands-menquadfi-082017938.html
Sanofi’s MenQuadfi approved in EU for infants against meningococcal disease
August 5, 2026  |  msn.comhttps://www.msn.com/en-us/health/general/sanofi-s-menquadfi-approved-in-eu-for-infants-against-meningococcal-disease/ar-AA29mF40
Why Investors Should Look at L3Harris, Cenovus, and Sanofi
August 5, 2026  |  baystreet.cahttps://www.baystreet.ca/stockstowatch/23782/Why-Investors-Should-Look-at-L3Harris-Cenovus-and-Sanofi
Press Release: Sanofi's MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease
August 4, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/04/3338016/0/en/press-release-sanofi-s-menquadfi-approved-in-the-eu-for-use-in-infants-from-age-six-weeks-against-invasive-meningococcal-disease.html
Sanofi SA (SNY) (Q2 2026) Earnings Call Highlights: Strong Sales Growth and Upgraded Guidance ...
August 1, 2026  |  sg.finance.yahoo.comhttps://sg.finance.yahoo.com/news/sanofi-sa-sny-q2-2026-190357494.html
Sanofi says weak decision-making hurt pipeline, promises more disciplined R&D
July 30, 2026  |  msn.comhttps://www.msn.com/en-us/money/news/sanofi-says-weak-decision-making-hurt-pipeline-promises-more-disciplined-r-d/ar-AA295zOh
Press Release: Sanofi’s half-year financial report for 2026
July 30, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/press-release-sanofi-s-half-year-financial-report-for-2026-1036385587
Sanofi Q2 Business Earnings, Sales Rise; Raises 2026 Sales Guidance
July 30, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/sanofi-q2-business-earnings-sales-090646150.html
Sanofi beats Q2 growth expectations on Dupixent sales surge
July 30, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4621266-sanofi-beats-q2-growth-expectations-on-dupixent-sales-surge
Sanofi Raises Guidance as New CEO Looks to Revamp Drug Pipeline
July 30, 2026  |  wsj.comhttps://www.wsj.com/business/retail/sanofi-raises-guidance-as-new-ceo-looks-to-revamp-drug-pipeline-629d09b6
Sanofi raises sales outlook on Dupixent strength in boost for new CEO
July 30, 2026  |  reuters.comhttps://www.reuters.com/legal/litigation/sanofi-raises-sales-outlook-dupixent-strength-boost-new-ceo-2026-07-30/
Sanofi to Drop Eczema Drug Amid Review of Pipeline Under New CEO
July 24, 2026  |  wsj.comhttps://www.wsj.com/health/pharma/sanofi-to-drop-eczema-drug-amid-review-of-pipeline-under-new-ceo-dae93b94
Press Release: Sanofi announces decision not to submit amlitelimab in atopic dermatitis for global regulatory reviews
July 24, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/24/3332696/0/en/press-release-sanofi-announces-decision-not-to-submit-amlitelimab-in-atopic-dermatitis-for-global-regulatory-reviews.html
Press Release: Sanofi evolves its Executive Committee to support its next strategic chapter
July 21, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/21/3330752/0/en/press-release-sanofi-evolves-its-executive-committee-to-support-its-next-strategic-chapter.html
Kalshi offers wagers on clinical trials and drug approvals
July 16, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4614520-kalshi-offers-wagers-clinical-trials-drug-approvals
Kalshi will let traders bet on FDA drug approvals despite critics' insider trading warnings
July 16, 2026  |  msn.comhttps://www.msn.com/en-us/money/general/kalshi-will-let-traders-bet-on-fda-drug-approvals-despite-critics-insider-trading-warnings/ar-AA284AJp
Analysts Conflicted on These Healthcare Names: Sanofi (SNY) and Johnson & Johnson (JNJ)
July 12, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/SNY-Q/pressreleases/3240016/analysts-conflicted-on-these-healthcare-names-sanofi-sny-and-johnson-johnson-jnj/
Press Release: Sanofi's subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector
July 10, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/10/3325483/0/en/press-release-sanofi-s-subcutaneous-sarclisa-escena-approved-in-the-us-as-first-anticancer-treatment-administered-via-on-body-injector.html
US FDA approves Sanofi's wearable injector form of blood cancer drug
July 10, 2026  |  reuters.comhttps://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-sanofis-wearable-injector-form-blood-cancer-drug-2026-07-10/
Sanofi offers to stop disparaging CSL’s flu vaccine after EU probe
July 8, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/sanofi-offers-to-stop-disparaging-csl-s-flu-vaccine-after-eu-probe/ar-AA27u7MC
EU seeks feedback on Sanofi's commitments addressing suspected anti-competitive behaviour
July 8, 2026  |  reuters.comhttps://www.reuters.com/business/healthcare-pharmaceuticals/eu-seeks-feedback-sanofis-commitments-addressing-suspected-anti-competitive-2026-07-08/
Sanofi ADR
July 7, 2026  |  barrons.comhttps://www.barrons.com/market-data/stocks/sny/research-ratings?gaa_at=eafs
Sanofi SA ADR SNY N
July 2, 2026  |  morningstar.comM
Press Release: Availability of the aide-mémoire for Q2 2026 results
July 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/01/3320323/0/en/press-release-availability-of-the-aide-m%c3%a9moire-for-q2-2026-results.html
Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO) and Sanofi (SNY)
June 30, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/SNY/pressreleases/3046787/analysts-offer-insights-on-healthcare-companies-novo-nordisk-nvo-and-sanofi-sny/
EU launches antitrust probe into Sanofi over allegedly misleading flu vaccine claims (updated)
June 30, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/eu-launches-antitrust-probe-into-sanofi-over-allegedly-misleading-flu-vaccine-claims-updated/ar-AA26CCvL
Sanofi Faces EU Probe With Fines Possibly Reaching 10%
June 26, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/sanofi-faces-eu-probe-fines-173830502.html
EU Commission opens antitrust probe into Sanofi's flu vaccine campaign
June 26, 2026  |  reuters.comhttps://www.reuters.com/business/healthcare-pharmaceuticals/eu-commission-opens-antitrust-probe-into-sanofis-flu-vaccine-campaign-2026-06-26/
Press Release: Sanofi Foundation opens new chapter centered on future generations
June 25, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/25/3317281/0/en/press-release-sanofi-foundation-opens-new-chapter-centered-on-future-generations.html
Europe approves Sanofi's multiple sclerosis drug despite FDA rejection
June 23, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/europe-approves-sanofis-multiple-sclerosis-drug-despite-fda-rejection/ar-AA26m2wK
Sanofi Multiple Sclerosis Drug Gets EU Approval
June 23, 2026  |  wsj.comhttps://www.wsj.com/health/pharma/sanofi-multiple-sclerosis-drug-gets-eu-approval-19e15b4e
Press Release: Sanofi's Wayrilz approved in Japan to treat immune thrombocytopenia
June 23, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/23/3315701/0/en/press-release-sanofi-s-wayrilz-approved-in-japan-to-treat-immune-thrombocytopenia.html
Press Release: Sanofi appoints Paulo Fontoura as Global Head of R&D
June 22, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/22/3315046/0/en/press-release-sanofi-appoints-paulo-fontoura-as-global-head-of-r-d.html
Press Release: Sanofi's Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma
June 19, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/19/3314694/0/en/press-release-sanofi-s-sarclisa-subcutaneous-formulation-approved-in-japan-for-patients-with-multiple-myeloma.html
Sanofi 'Strong Buy': Continued Dupixent Sales Growth And Sarclisa OBI First
June 15, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4915133-sanofi-strong-buy-continued-dupixent-sales-growth-and-sarclisa-obi-first
Sanofi type 1 diabetes therapy Tzield approved in U.S. for stage 3 of the disease
June 15, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4603104-sanofi-wins-label-expansion-type-1-diabetes-drug-tzield
Sanofi: Information concerning the total number of voting rights and shares – May 2026
June 15, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/15/3312003/0/en/sanofi-information-concerning-the-total-number-of-voting-rights-and-shares-may-2026.html
FDA approves Sanofi's drug for stage 3 type 1 diabetes in children
June 12, 2026  |  reuters.comhttps://www.reuters.com/legal/litigation/fda-approves-sanofis-drug-stage-3-type-1-diabetes-children-2026-06-12/
Wayrilz (rilzabrutinib, Sanofi) Positioned to Define Third-Line Treatment in Warm Autoimmune Hemolytic Anemia (w-AIHA) as IMAAVY (niopcalimab, Jonhson & Johnson) Follows Closely with Positive Data Announcement at EHA 2026
June 12, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/12/3311029/0/en/wayrilz-rilzabrutinib-sanofi-positioned-to-define-third-line-treatment-in-warm-autoimmune-hemolytic-anemia-w-aiha-as-imaavy-niopcalimab-jonhson-johnson-follows-closely-with-positiv.html
Sanofi, an Argenx rival, bites the dust — but a third biotech took the biggest hit
June 10, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/sanofi-an-argenx-rival-bites-the-dust-but-a-third-biotech-took-the-biggest-hit/ar-AA25iift

Sanofi Media Mentions By Week

Sanofi Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SNY
News Sentiment
▼
0.47

0.77
▲
Average
Healthcare
News Sentiment

Sanofi News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SNY Articles
This Week
▼
1

7
▲
SNY Articles
Average Week

Sanofi Trends on MarketBeat

This week vs. last week
New Followers
1
Searches
2
-67%
Page Views
3,949
-5%
Get Sanofi News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools

Related Companies
News and Trends Tools

MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Sanofi dated 8/29/2026.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel